SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report:
(Date of earliest event reported)
November 29, 2012
DIAGNOSTIC IMAGING INTERNATIONAL CORP.
(Exact name of registrant as specified in charter)
(State or other Jurisdiction of Incorporation or Organization)
848 N. Rainbow Blvd. #2494
Las Vegas, Nevada 89107
(Commission File Number)
(Address of Principal Executive Offices and zip code)
(IRS Employer Identification No.)
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into Material Definitive Agreement.
On November 29, 2012, Diagnostic Imaging International Corp. (the Company) entered into an amendment of the Share Purchase Agreement with the owners of an MRI facility (the Facility) that was originally agreed to on August 13, 2012. The new amendment extends the closing date of the original transaction to December 10, 2012.
Consummation of the transaction is subject to certain customary closing conditions, including, among other things, the satisfactory completion of the Companys due diligence review of the Facility, the continued regulatory compliance of the Facility, and the continued employment of specified personnel of the Facility. Additionally, the acquisition of the Facility may be abandoned by the Company at any time, in its sole discretion.
The Company has paid a $40,000 deposit and is currently holding sufficient funds in escrow to complete the transaction and, subject to the satisfaction or waiver of all closing conditions, and the closing of the necessary financing, the Company expects to close the transaction by December 10, 2012.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
Diagnostic Imaging International Corp.
Dated: November 30, 2012
/s/ Mitch Geisler
Name: Mitch Geisler